272 results on '"Capparelli E"'
Search Results
2. Shallow Encoding and Forgetting Are Associated with Dependence in Instrumental Activities of Daily Living Among Older Adults Living with HIV Infection
3. POS0872 CHARACTERIZATION AND RISK FACTORS FOR LUNG INVOLVEMENT IN PSORIATIC ARTHRITIS: DATA FROM A SINGLE RHEUMATOLOGIC CENTRE
4. Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults
5. Oral Ganciclovir in Children: Pharmacokinetics, Safety, Tolerance, and Antiviral Effects
6. Alteration in cytochrome P450 3A4 activity as measured by a urine cortisol assay in HIV-1-infected pregnant women and relationship to antiretroviral pharmacokinetics
7. Use of Opportunistic Clinical Data and a Population Pharmacokinetic Model to Support Dosing of Clindamycin for Premature Infants to Adolescents
8. Safety and PK of potent anti-HIV monoclonal AB VRC07-523LS in HIV-exposed infants
9. Effect of pregnancy on emtricitabine pharmacokinetics*
10. Assessment of Lopinavir Pharmacokinetics With Respect to Developmental Changes in Infants and the Impact on Weight Band-Based Dosing
11. Safety and Pharmacokinetics of Multiple-Dose anidulafungin in Infants and Neonates
12. Lopinavir protein binding in HIV-1-infected pregnant women
13. Abacavir Pharmacokinetics During Chronic Therapy in HIV-1-Infected Adolescents and Young Adults
14. Personalized Therapeutics: HIV Treatment in Adolescents
15. Acetaminophen-Associated Hepatic Injury: Evaluation of Acetaminophen Protein Adducts in Children and Adolescents With Acetaminophen Overdose
16. Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartum
17. Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics
18. Pharmacokinetics and Safety of Nelfinavir When Used in Combination with Zidovudine and Lamivudine in HIV-Infected Pregnant Women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353
19. A multicenter, randomized, placebo controlled, multiple-dose, safety and pharmacokinetic study of AIT-082 (Neotrofin™) in mild Alzheimerʼs disease patients
20. O36 Physiologically based pharmacokinetic models to predict fetal exposure to antiviral drugs
21. The effect of deep posterior subtenon injection of corticosteroids on intraocular pressure
22. Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women
23. Editorial: The CB2 Cannabinoid System: A New Strategy in Neurodegenerative Disorder and Neuroinflammation
24. Vascular toxicity risk assessment of MC18 and MC70, novel potential diagnostic tools for in vivo PET studies
25. Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women
26. Use of Opportunistic Clinical Data and a Population Pharmacokinetic Model to Support Dosing of Clindamycin for Premature Infants to Adolescents
27. Reduced indinavir exposure during pregnancy
28. CHARACTERIZATION AND RISK FACTORS FOR LUNG INVOLVEMENT IN PSORIATIC ARTHRITIS: DATA FROM A SINGLE RHEUMATOLOGIC CENTRE.
29. Il counseling familiare nel disturbo specifico dell'apprendimento
30. Expression of mannose binding lectin in HIV-1-infected brain: Implications for HIV-related neuronal damage and neuroaids
31. Proposta di un questionario on-line per la valutazione della qualità della voce e del disagio acustico nelle aule universitarie
32. Proposta di un questionario on-line per la valutazione della qualità della voce e del disagio acustico nelle aule universitarie
33. Il Tinnitu Handicap Inventory (THI) come test di screening per la comorbilità psichiatrica nei soggetti affetti da acufeni'
34. Lenalidomide exerts cytostatic activity on melanoma cells by negative regulation of their cell cycle
35. Development of an electrochemical biosensor for water toxicity
36. TECNOLOGIE E PROCEDURE DEGLI SCREENING UDITIVI NEONATALI
37. Influence of CYP2B6 polymorphisms on the persistence of plasma nevirapine concentrations following a single intra-partum dose for the prevention of mother to child transmission in HIV-infected Thai women
38. The THI questionnaire: Psychometric data for reliability and validity of the Italian version
39. A.I.R.S. (Italian Association for Research on Deafness) Tinnitus and Hyperacusis Clinic: our experience
40. Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancy
41. From Pediatric Covariate Model to Semiphysiological Function for Maturation: Part I–Extrapolation of a Covariate Model From Morphine to Zidovudine
42. Assessment of Lopinavir Pharmacokinetics With Respect to Developmental Changes in Infants and the Impact on Weight Band–Based Dosing
43. Effect of pregnancy on emtricitabine pharmacokinetics
44. Gabapentin for chronic back pain: a randomized clinical trial
45. Influence of CYP2B6 polymorphisms on the persistence of plasma nevirapine concentrations following a single intra-partum dose for the prevention of mother to child transmission in HIV-infected Thai women
46. Nelfinavir (NFV) population pharmacokinetics (PK) in long-term suppressors compared with the pk of the new 625 mg formulation in healthy volunteers
47. Zydis selegiline population pharmacokinetics from sparse data: Dosing implication
48. Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources
49. Intestinal fatty-acid binding protein and metronidazole response in premature infants.
50. Pharmacokinetics of zidovudine in infants: A population analysis across studies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.